Sotera Health Co(SHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 31.2 | EPS (ttm) | 0.57 | Insider Own | 2.1% | Shs Outstand | 285.4M | Perf Week | -3.53% |
| Market Cap | 5.06B | Forward P/E | 16.5 | EPS next Y | 9.23% | Insider Trans | -89.71% | Shs Float | 279.4M | Perf Month | -2.63% |
| Enterprise Value | 6.97B | PEG | 1.47 | EPS next Q | 0.27 | Inst Own | 104.45% | Short Float | 5.76% | Perf Quarter | -2.04% |
| Income | 0.16B | P/S | 4.16 | EPS this Y | 14.42% | Inst Trans | -4.33% | Short Ratio | 7.11 | Perf Half Y | 15.27% |
| Sales | 1.22B | P/B | 7.61 | EPS next 5Y | 11.19% | ROA | 5.01% | Short Interest | 16.09M | Perf YTD | 0.57% |
| Book/sh | 2.33 | P/C | 14.19 | EPS past 3/5Y | - | ROE | 27.78% | 52W High | -10.63% ($19.85) | Perf Year | 6.87% |
| Cash/sh | 1.25 | P/FCF | 46.12 | Sales past 3/5Y | 5.05% 7.3% | ROIC | 5.62% | 52W Low | 35.52% ($13.09) | Perf 3Y | 38.49% |
| Dividend Est. | $0.01 (0.06%) | EV/EBITDA | 12.1 | EPS Y/Y TTM | 576.89% | Gross Margin | 53.97% | Volatility(W/M) | 3.12% 3% | Perf 5Y | -31.66% |
| Dividend TTM | - | EV/Sales | 5.73 | Sales Y/Y TTM | 8.15% | Oper. Margin | 36.9% | ATR (14) | 0.52 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.53 | EPS Q/Q | 567.38% | Profit Margin | 13.44% | RSI (14) | 42.04 | Recom | 1.64 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.8 | Sales Q/Q | 9.18% | SMA20 | -1.93% ($18.09) | Beta | 1.94 | Target Price | $22.61 |
| Payout | - | Debt/Eq | 3.41 | Earnings | 2026/11/3 | SMA50 | -4.02% ($18.48) | Rel Volume | 1.41 | Prev Close | $18.15 |
| Employees | 3000 | LT Debt/Eq | 3.37 | EPS/Sales Surpr. | 8.83% 3.77% | SMA200 | 4.39% ($16.99) | Avg Volume(3M) | 2.26M | Price | $17.74 |
| IPO | 2020/11/20 | Option/Short | Yes/Yes | Trades | 22203 | Volume | 3,184,835 | Change | -2.26% |
🧪 A global healthcare services company that provides sterilization and laboratory testing services for the medical device and pharmaceutical industries. It offers gamma, ethylene oxide, and electron beam sterilization along with laboratory testing and consulting services, serving as essential infrastructure for the medical device and pharmaceutical industries. The business is characterized by a stable structure based on non-discretionary demand.
Over the past 1 year, roughly in the middle
11% below its 1-year high.
Traded more than usual. That is 141% of its average volume.
Next earnings report: November 3
That is today.
SHC makes money exceptionally well
Of every $100 in sales, $36.90 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.4% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company expected to earn $100 next year, you would pay $1,650. Peers typically go for $2,608. Compared with its own 4-year average, it is 47% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -31.7%. The S&P 500 did +63% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.06% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 104.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #21 of 44 in the industry
Based on market cap of $5B.
GRAL#18 GRAIL Inc $6B PER - 
RDNT#19 Radnet Inc $6B PER - 
BLLN#20 Billiontoone Inc $5B PER 179.2 SHC#21 Sotera Health Co $5B PER 31.2 
CDNA#22 Caredx Inc $5B PER 35.9 
FAQ
What kind of company is SHC?
SHC belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of SHC?
The market cap of SHC is approximately $5.1B, ranking 1,368 within its sector.
Does SHC pay dividends?
SHC has a dividend yield of approximately 0.06%, with an annual dividend of $0.01.
What is the P/E ratio of SHC?
SHC has a P/E ratio of approximately 31.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SHC?
SHC has recorded a 52-week high of $19.85 and a low of $13.09.
